pancreatitis and semaglutide Study: Weight Loss Drugs Linked to Can Semaglutide Cause Pancreatitis? |

Only FDA-approved semaglutide products (Ozempic, Wegovy, Rybelsus) have established safety and efficacy profiles

The most common side effect of statin is statin-associated muscle symptoms (SAMSs), reported by 10% to 25% of patients receiving statin therapy

India GLP-1 Receptor Agonists Obesity Drugs Market Insight The India GLP-1 receptor agonists obesity drugs accounted for the largest revenue share in Asia Pacific in 2024, driven by a growing obesity burden, increasing healthcare awareness, and the rapid expansion of urban healthcare infrastructure

However, the effects of the BASs on GLP-1 secretion are controversial

Faggiano, A

However, this difference was modest and did not translate to higher discontinuation rates